These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8348421)

  • 1. Addressing the pharmaceutical industry's influence on professional behaviour.
    Woollard RF
    CMAJ; 1993 Aug; 149(4):403-4. PubMed ID: 8348421
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of residency program guidelines for interaction with the pharmaceutical industry. Education Council, Residency Training Programme in Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ont.
    CMAJ; 1993 Aug; 149(4):405-8. PubMed ID: 8348422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Academic medicine and the pharmaceutical industry: a cautionary tale.
    Guyatt G
    CMAJ; 1994 Mar; 150(6):951-3. PubMed ID: 8131127
    [No Abstract]   [Full Text] [Related]  

  • 4. Proposed guidelines for housestaff interaction with pharmaceutical companies.
    Forrest DM; Ruedy J
    Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faculties of health sciences and the pharmaceutical industry: an effective partnership.
    Forrest JB
    CMAJ; 1994 Nov; 151(9):1320-2. PubMed ID: 7954182
    [No Abstract]   [Full Text] [Related]  

  • 6. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.
    Brett AS; Burr W; Moloo J
    Arch Intern Med; 2003 Oct; 163(18):2213-8. PubMed ID: 14557219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the pharmaceutical industry in teaching psychopharmacology: a growing problem.
    Brodkey AC
    Acad Psychiatry; 2005; 29(2):222-9. PubMed ID: 15937271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Policy recommendations for pharmaceutical representative-resident interactions.
    Brotzman GL; Mark DH
    Fam Med; 1992 Aug; 24(6):431-2. PubMed ID: 1397812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario.
    Sergeant MD; Hodgetts PG; Godwin M; Walker DM; McHenry P
    CMAJ; 1996 Nov; 155(9):1243-8. PubMed ID: 8911290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Network for supervising directors of studies proposes competence goals for internship mentors].
    Kihlström L; Borna P; Björgell O; Karlander S; Johansson A; Kling A; Walentin F; Antepohl W
    Lakartidningen; 2010 Apr 14-20; 107(15):1000-1. PubMed ID: 20464918
    [No Abstract]   [Full Text] [Related]  

  • 11. Bias in medical education? Take my word for it!
    Schulte J
    Med Econ; 1991 Aug; 68(16):171-2, 174. PubMed ID: 10112344
    [No Abstract]   [Full Text] [Related]  

  • 12. A study of interactions between pharmaceutical representatives and ophthalmology trainees.
    Wang Y; Adelman RA
    Am J Ophthalmol; 2009 Oct; 148(4):619-622.e3. PubMed ID: 19570520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relations with the pharmaceutical industry.
    Lexchin J
    CMAJ; 1994 Aug; 151(4):413-4; author reply 415. PubMed ID: 8055397
    [No Abstract]   [Full Text] [Related]  

  • 14. [Residents and pharmaceutical industry].
    Chabot JM
    Rev Prat; 2004 Apr; 54(8):875-6. PubMed ID: 15274462
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical residents and the pharmaceutical industry.
    Rosner F
    Arch Intern Med; 1992 Dec; 152(12):2507. PubMed ID: 1456867
    [No Abstract]   [Full Text] [Related]  

  • 16. Key aspects of physician and pharmaceutical industry relationships for trainees.
    Jain S
    Acad Psychiatry; 2010; 34(2):98-101. PubMed ID: 20224015
    [No Abstract]   [Full Text] [Related]  

  • 17. Residents and pharmaceutical representatives.
    Lexchin J
    Can Fam Physician; 1998 Jul; 44():1448. PubMed ID: 9678269
    [No Abstract]   [Full Text] [Related]  

  • 18. Interacting with the pharmaceutical industry.
    Stopps RG
    CMAJ; 1994 Sep; 151(6):731-2. PubMed ID: 8087746
    [No Abstract]   [Full Text] [Related]  

  • 19. Guidelines for interaction with the pharmaceutical industry.
    Colby WD
    CMAJ; 1995 Apr; 152(7):1040-2. PubMed ID: 7712409
    [No Abstract]   [Full Text] [Related]  

  • 20. Commentary: Addressing corporate influence through ethical guidelines.
    Greenland S
    Int J Epidemiol; 2008 Feb; 37(1):57-9; discussion 65-8. PubMed ID: 18245052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.